The Scientist

» US Supreme Court

Most Recent

image: Myriad, Post Mortem

Myriad, Post Mortem

By | June 1, 2016

David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.

0 Comments

image: Governing Science

Governing Science

By | December 31, 2013

How the US government impacted life science research in 2013

1 Comment

image: Criminal Hype

Criminal Hype

By | September 25, 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

0 Comments

image: Speaking of Science

Speaking of Science

By | August 1, 2013

August 2013's selection of notable quotes

0 Comments

image: Another Lawsuit over Genetic Tests

Another Lawsuit over Genetic Tests

By | July 11, 2013

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

0 Comments

image: Speaking of Science

Speaking of Science

By | July 1, 2013

July 2013's selection of notable quotes

3 Comments

image: Gene Patents Decision: Everybody Wins

Gene Patents Decision: Everybody Wins

By | June 18, 2013

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

4 Comments

image: Opinion: On Patenting Genes

Opinion: On Patenting Genes

By | June 18, 2013

The scientific community and the impact of the Myriad Genetics Supreme Court decision

1 Comment

image: Week in Review, June 10–14

Week in Review, June 10–14

By | June 14, 2013

Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration

0 Comments

image: Supreme Court Nixes Patenting Human Genes

Supreme Court Nixes Patenting Human Genes

By | June 13, 2013

The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.  

4 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham